Death · people with CKD
1 finding from 1 review
Death · people with CKD
Educational interventions and self‐management training showed no clear difference in death compared with usual care (moderate certainty).
1 finding from 1 review
Death · people with CKD
1 finding from 1 review
Death · postmenopausal women with osteoporosis and CKD stages 5 and 5D
It is very uncertain whether raloxifene changes death compared with placebo (very low certainty).
1 finding from 1 review
Death · postmenopausal women with osteoporosis and CKD stages 3‐4
1 finding from 1 review
Death at 2 years · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in death at 2 years compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Death (any cause) · adult lung transplant recipients
1 finding from 1 review
Death (any cause) · adult lung transplant recipients
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with CKD who are overweight or obese
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · people with ESKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death at 6 months · people with CKD
Uric acid lowering therapies (UAR) showed no clear difference in death at 6 months compared with placebo, no treatment or usual care (low certainty).
1 finding from 1 review
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Sevelamer changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Death (all causes) · people with CKD
Summary of findings: Iron showed no clear difference in death (all causes) compared with placebo/usual care (low certainty).
1 finding from 1 review
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Calcium changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Death (all causes) · people with CKD
It is very uncertain whether summary of findings: Lanthanum changes death (all causes) compared with placebo/usual care (very low certainty).
1 finding from 1 review
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Cardiovascular mortality · people with CKD
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found